Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Cash from Financing Activities (2016 - 2025)

Healthstream (HSTM) has disclosed Cash from Financing Activities for 16 consecutive years, with -$7.2 million as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities fell 601.26% to -$7.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$36.3 million through Dec 2025, down 703.08% year-over-year, with the annual reading at -$36.3 million for FY2025, 703.08% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$7.2 million at Healthstream, up from -$7.9 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was -$20000.0 in Q3 2022, with the low at -$20.2 million in Q1 2022.
  • Average Cash from Financing Activities over 5 years is -$4.4 million, with a median of -$1.7 million recorded in 2024.
  • The sharpest move saw Cash from Financing Activities surged 99.18% in 2022, then plummeted 17502.13% in 2023.
  • Over 5 years, Cash from Financing Activities stood at -$5.7 million in 2021, then soared by 99.18% to -$47000.0 in 2022, then tumbled by 17502.13% to -$8.3 million in 2023, then surged by 87.51% to -$1.0 million in 2024, then tumbled by 601.26% to -$7.2 million in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at -$7.2 million, -$7.9 million, and -$19.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.